The Propaganda for Reform in Proprietary Medicines, Vol. 1 of 2Council on Pharmacy and Chemistry (American Medical Association)
Science
The Propaganda for Reform in Proprietary Medicines, Vol. 1 of 2
Council on Pharmacy and Chemistry (American Medical Association)
Patent medicines
“The literature still sent out by Parke, Davis & Co. regarding
Taka-Diastase is misleading and of a kind more appropriate for a
nostrum than a standard chemical substance. What would we think if
morphin, quinin or even heroin were advertised in the same way? I
cite the statement, ‘Taka-Diastase digests starchy food with vigor
and directness.’ It seems to the referee that the proposition to
modify the label to indicate the amount of starch which is liquefied
rather than the amount which is saccharified, in accordance with the
Council’s standard, is bound to lead to confusion and to give an
exaggerated and false value to Taka-Diastase.
“Your referee recommends that the report of the reinvestigation of
Taka-Diastase which has been submitted to me, be made available to
the medical profession, and that the rejection of Taka-Diastase and
Liquid Taka-Diastase be allowed to stand.”
This report of the second referee was submitted to Parke, Davis & Co.,
with the request that they state more explicitly their claims regarding
the activity of Taka-Diastase and Liquid Taka-Diastase, in order that,
if they decided to revise their claims for the preparations, such
revision of claims might be published along with the reports of the
Council. They replied:
“Answering your note of the 15th instant: We have no desire to
discuss further the subject of your letter of February 24, or to make
any statement beyond that set forth in our letter to you of Dec. 27,
1911.”--(_From The Journal A. M. A., July 6, 1912._)
DIGALEN OMITTED FROM N. N. R.
Report of the Council on Pharmacy and Chemistry
Digalen is a proprietary said to contain a soluble form (digitoxinum
solubile Cloetta) of digitoxin, the chief active principle of
digitalis. This preparation was accepted[25] by the Council in 1909
for inclusion in New and Nonofficial Remedies. The Council had not
at that time determined whether Digalen contained “soluble amorphous
digitoxin,” as claimed, or not. The product was accepted merely as a
standardized soluble and fairly stable digitalis preparation.
[25] The Journal A. M. A., Sept. 11, 1909, p. 869.
Public-domain text, read in full here on John Shaqi.
Reviews
Reviews
No reviews yet
Be the first to share your thoughts on this work.
Elsewhere in the archive
Join the Discussion
Join the discussion
Sign in to leave a comment or review.
Sign InorCreate an account